422 related articles for article (PubMed ID: 37834246)
1. Mesenchymal Stem Cells in the Treatment of COVID-19.
Guo BC; Wu KH; Chen CY; Lin WY; Chang YJ; Lee TA; Lin MJ; Wu HP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834246
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
3. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
4. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
6. Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19.
Wu KH; Chao YH; Weng TF; Li JP
Curr Pharm Des; 2022; 28(36):2991-2994. PubMed ID: 36165526
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
[TBL] [Abstract][Full Text] [Related]
8. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
10. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R
Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985
[TBL] [Abstract][Full Text] [Related]
11. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
